Cite

HARVARD Citation

    Mylvaganam, R. et al. (2021). Adverse effects of immune checkpoint inhibitor therapies on right ventricular function and pulmonary arterial dilatation. Pulmonary circulation. p. . [Online]. 
  
Back to record